Skip to content
Tech News
← Back to articles

A robot could eventually conduct your blood draw at the doctor's office

read original more articles
Why This Matters

The FDA's approval of Aletta marks a significant step toward automating routine medical procedures like blood draws, addressing workforce shortages and improving efficiency in healthcare. This innovation has the potential to streamline outpatient services, reduce wait times, and enhance patient experience. As automation advances, it could reshape how medical procedures are performed and managed in clinics nationwide.

Key Takeaways

The US Food and Drug Administration has approved a new product aimed at automating blood draws in outpatient situations. Aletta is a standalone robotic device capable of drawing blood from a patient's arm. It uses near-infrared light and Doppler ultrasound to identify a vein and then automates the other processes of a blood draw, such as applying a tourniquet, inserting and disposing of a needle and placing a bandage on the patient. A trained phlebotomist must begin the procedure and oversee the device while it is in use, but a single person can monitor up to three Aletta robots at once.

"Blood draws are one of the most commonly performed medical procedures in the United States, yet patients may face delays due to a growing shortage of trained phlebotomists." said Michelle Tarver, director of the FDA's Center for Devices and Radiological Health. The approval for Aletta was granted based on clinical data showing it was capable of successful blood draws at rates comparable to or better than a phlebotomist.

While Aletta may have FDA approval, there's no word yet on when we'll actually start seeing these in doctors' offices.